Evaluation of antibacterial activity and cytocompatibility of α-TCP based bone cements with silver-doped hydroxyapatite and CaCO3
Source abstract
Abstract
Abstract The implant-related infections are a severe problem in orthopedic surgery. In this work, bone cements based on α-TCP, silver doped hydroxyapatite and calcite were examined. Developed bioactive materials revealed good surgical handiness and appropriate setting times allowing for their application. In order to assess antibacterial properties, two independent experiments (test imitating in vivo conditions and test of cumulative extraction) were used. It was found that bone cement matrix do not impede the Ag + release from the Ag-HA agglomerates. Materials showed mild antibacterial activity which depended on the kind of bacterial strain and the type of test. Presence of silver in the tested materials increased the antibacterial activity in the extracts only for E. coli strain and the effect was transient. In the case of Gram-positive strains ( S. aureus and S. epidermidis ), antibacterial activity was most probably connected with the properties of cement material, not with the content of silver. Observed reduction of osteoblast viability in vitro resulted from the synergic effect: decrease in concentrations of Ca 2+ , Mg 2+ , and PO 4 3- ions in the culture medium and the presence of silver ions.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Biocompatibility of calcium phosphate bone cement with optimized mechanical properties10.1002/jbm.b.33370 ↗
2. Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties10.1016/j.actbio.2013.11.001 ↗
3. Calcium phosphate bone cements for local vancomycin delivery10.1016/j.msec.2014.12.075 ↗
4. A new calcium phosphate water setting cement
5. Injectability evaluation of tricalcium phosphate bone cement10.1007/s10856-007-3329-6 ↗
6. Polymeric-calcium phosphate cement composites-material properties: in vitro and in vivo investigations10.1155/2010/691452 ↗
7. Trabecular bone response to injectable calcium phosphate (Ca-P) cement10.1002/jbm.10029 ↗
8. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate-chitosan composite scaffold10.1016/j.biomaterials.2009.01.022 ↗
9. Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements10.1016/S0142-9612(00)00413-0 ↗
10. Preparation, physical-chemical characterisation and cytocompatibility of calcium carbonate cements10.1016/j.biomaterials.2005.09.026 ↗
11. Polymeric additives to enhance the functional properties of calcium phosphate cements10.1177/2041731412439555 ↗
12. Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements10.1016/S0142-9612(02)00153-9 ↗
13. Improvement of anti-washout performance of calcium phosphate cement using modified starch10.4028/www.scientific.net/KEM.336-338.1628 ↗
14. A novel injectable, cohesive and toughened Si-HPMC (silanized-hydroxypropyl methylcellulose) composite calcium phosphate cement for bone substitution10.1016/j.actbio.2014.03.009 ↗
15. The importance of chitosan and nano-TiHA in cement-type composites on the basis of calcium sulfate10.1016/j.ceramint.2016.07.003 ↗
16. Physical and chemical aspects of calcium phosphates used in spinal surgery
17. Effects of polysaccharides on the cement properties in the monocalcium phosphate/b-tricalcium phosphate system
18. Polymeric additives to enhance the functional properties of calcium phosphate cements10.1177/2041731412439555 ↗
19. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review10.1016/j.actbio.2011.11.017 ↗
20. Silver-doped calcium phosphate cements with antimicrobial activity10.1016/j.actbio.2011.06.049 ↗
21. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement10.1016/S0883-5403(96)80135-5 ↗
22. Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment10.1016/j.biomaterials.2005.05.072 ↗
23. A novel antibacterial titania coating: metal ion toxicity and in vitro surface colonization10.1007/s10856-005-4422-3 ↗
24. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating10.1016/j.biomaterials.2006.07.003 ↗
25. Antimicrobial effects and human gingival biocompatibility of hydroxyapatite sol-gel coatings10.1002/jbm.b.30365 ↗
26. Antiseptics and disinfectants: activity, action, and resistance10.1128/CMR.12.1.147 ↗
27. The role of Acticoat TM with nanocrystalline silver in the management of burns10.1016/S0305-4179(04)90000-9 ↗
28. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment10.1053/ic.1998.v26.a93527 ↗
29. Infection and the chronic wound: a focus on silver10.1097/00129334-200510001-00001 ↗
30. Matrix metalloproteinases in normal and impaired wound healing: a potential role for nanocrystalline silver
31. Ionic substitutions in calcium phosphates synthesized at low temperature10.1016/j.actbio.2009.12.041 ↗
32. Silver-doped calcium phosphate bone cements with antibacterial properties10.3390/jfb7020010 ↗
33. Synthesis and characterization of a novel silver-substituted calcium phosphate cement10.1016/j.jmst.2014.03.005 ↗
34. ASTM C266-04, Standard Test Method for Time Setting of Hydraulic-cement Paste by Gillmore Needles, ASTM Annual Book of standards, PA 19428–2959, USA.
35. In vitro evaluation of bioactivity
36. Bioactive delivery systems for the slow release of antibiotics: incorporation of Ag+ ions into micro-porous hydroxyapatite coatings10.1016/0167-577X(95)00059-3 ↗
37. Structural properties of silver doped hydroxyapatite and their biocompatibility10.1016/j.msec.2012.12.042 ↗
38. Self-setting calcium orthophosphate formulations: cements, concretes, pastes and putties
39. Osteotransductive bone cements10.1243/0954411981534196 ↗
40. Rheological properties of an apatitic bone cement during initial setting10.1023/A:1012832325957 ↗
41. Self-setting bioactive calcium-magnesium phosphate cement with high strength and degradability for bone regeneration10.1016/j.actbio.2008.06.020 ↗
42. Correlating crystallinity and reactivity in an α-tricalcium phosphate10.1016/j.biomaterials.2004.08.001 ↗
43. α-tricalcium phosphate hydrolysis to hydroxyapatite at and near physiological temperature10.1023/A:1008934024440 ↗
44. Antimicrobial activity and action of silver10.1016/S0079-6468(08)70024-9 ↗
45. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli10.1128/AEM.02001-07 ↗
46. Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering10.1016/j.apsusc.2010.12.113 ↗
47. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver10.1016/S0305-4179(99)00116-3 ↗
48. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
49. Strain specificity in antimicrobial activity of silver and copper nanoparticles10.1016/j.actbio.2007.11.006 ↗
50. Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions10.1016/S0109-5641(00)00050-6 ↗
51. α′H-Dicalcium silicate bone cement doped with tricalcium phosphate: characterization, bioactivity and biocompatibility10.1007/s10856-013-5084-1 ↗
52. Physicochemical properties and biomimetic behaviour of α-TCP-chitosan based materials10.1016/j.ceramint.2013.10.142 ↗
53. Hydrolysis of α-tricalcium phosphate in simulated body fluid and dehydration behavior during the drying process10.1111/j.1551-2916.2007.01682.x ↗
54. Bioactive materials10.1016/0272-8842(95)00126-3 ↗
55. Do novel cement-type biomaterials reveal ion reactivity that affects cell viability in vitro?
56. Ion reactivity of calcium-deficient hydroxyapatite in standard cell culture media10.1016/j.actbio.2011.07.016 ↗
57. Bilayered chitosan-based scaffolds for osteochondral tissue engineering: influence of hydroxyapatite on in vitro cytotoxicity and dynamic bioactivity studies in a specific double-chamber bioreactor10.1016/j.actbio.2008.09.017 ↗
58. “False” cytotoxicity of ions-adsorbing hydroxyapatite – corrected method of cytotoxicity evaluation for ceramics of high specific surface area10.1016/j.msec.2016.03.105 ↗
59. Effect of silver nanoparticles on human mesenchymal stem cell differentiation10.3762/bjnano.5.214 ↗
60. Evaluation of the effects of Ag ion concentration on osteoblast activity10.4028/www.scientific.net/KEM.631.390 ↗
61. Cytotoxic effects of ionic silver and silver nano-particles on osteoblasts and osteoclasts in vitro